Advertisement

COVID-19 variants Mu, C.1.2 variants not found in India so far, says genome sequencing panel

The consortium has called for more strongly implementing existing recommendations on sequencing of positive samples from international travellers.

Advertisement
|Sep 15, 2021, 14:29:57 IST

New Delhi: India has so far not seen Mu and C.1.2, the two new variants of SARS-CoV2, and the Delta variant and its sub-lineages continue to the main Variants of Concern in the country, INSACOG, the genome sequencing consortium, has said.The consortium has called for more strongly implementing existing recommendations on sequencing of positive samples from international travellers.The World Health Organisation (WHO) has added B.1.621 (including B.1.621.1) to the list of Variants of Interest (VOI) on 30 August and christened it Mu. It has also added C.1.2 as a new VOI.C.1.2 is a sub-lineage of the C.1 variant described in South Africa but did not spread globally, the INSACOG said."Neither Mu, nor C.1.2 are seen in India so far. Existing recommendations on sequencing of positive samples from international travellers may be more strongly implemented. Monitoring and evaluation of further data appears to be adequate at this time," the INSACOG said in its bulletin dated 10 September."Delta and Delta sub-lineages continue to be the main VOC in India," it added. The Delta variant has been driving infections in several countries. In India, it led to a deadly second wave.The INSACOG said Mu has mutations that indicate potential immune escape properties. There appears to be a reduction in neutralisation capacity of convalescent and vaccine sera, similar to that seen for the Beta variant, but this needs to be confirmed by further studies.Although the global prevalence of the Mu variant has declined and is currently below 0.1 percent, the prevalence in Colombia (39 percent) and Ecuador (13 percent) has consistently increased, according to the WHO bulletin.It said the C.1.2 variant seems to have undergone many mutations in a short time, and contains mutations of all the three types that have previously been found to be important for transmissibility and immune escape.The only clinical data for actual transmissibility is a rise from 0.2 per cent in May to two percent in July, the INSACOG said.

Advertisement
Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Sep 15, 2021, 14:29:57 IST
Advertisement
Advertisement
Trending Stories

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.
2 min read
Advertisement
Advertisement
Up Next